162 related articles for article (PubMed ID: 24884941)
1. Human epidermal growth factor receptor 2-positive microinvasive breast carcinoma with a highly aggressive course: a case report.
Kuhar CG; Matos E
BMC Res Notes; 2014 May; 7():325. PubMed ID: 24884941
[TBL] [Abstract][Full Text] [Related]
2. [Breast ductal carcinoma in situ with microinvasion: pathological review and clinical implications].
Modesto A; Gandy C; Mery E; Filleron T; Massabeau C; Izar F; Charitansky H; Roché H; de Lafontan B
Cancer Radiother; 2014 Mar; 18(2):107-10. PubMed ID: 24637020
[TBL] [Abstract][Full Text] [Related]
3. Microinvasive ductal carcinoma (T1mic) of the breast. The clinicopathological profile and immunohistochemical features of 28 cases.
Yang M; Moriya T; Oguma M; De La Cruz C; Endoh M; Ishida T; Hirakawa H; Orita Y; Ohuchi N; Sasano H
Pathol Int; 2003 Jul; 53(7):422-8. PubMed ID: 12828606
[TBL] [Abstract][Full Text] [Related]
4. The hormone receptor, human epidermal growth factor receptor 2, and molecular subtype status of individual tumor foci in multifocal/multicentric invasive ductal carcinoma of breast.
Choi Y; Kim EJ; Seol H; Lee HE; Jang MJ; Kim SM; Kim JH; Kim SW; Choe G; Park SY
Hum Pathol; 2012 Jan; 43(1):48-55. PubMed ID: 21733550
[TBL] [Abstract][Full Text] [Related]
5. Microinvasive breast carcinoma carries an excellent prognosis regardless of the tumor characteristics.
Shatat L; Gloyeske N; Madan R; O'Neil M; Tawfik O; Fan F
Hum Pathol; 2013 Dec; 44(12):2684-9. PubMed ID: 24071019
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic analysis of a large series of microinvasive breast cancers.
Lillemoe TJ; Tsai ML; Swenson KK; Susnik B; Krueger J; Harris K; Rueth N; Grimm E; Leach JW
Breast J; 2018 Jul; 24(4):574-579. PubMed ID: 29476574
[TBL] [Abstract][Full Text] [Related]
7. Extent of microinvasion in ductal carcinoma in situ is not associated with sentinel lymph node metastases.
Matsen CB; Hirsch A; Eaton A; Stempel M; Heerdt A; Van Zee KJ; Cody HS; Morrow M; Plitas G
Ann Surg Oncol; 2014 Oct; 21(10):3330-5. PubMed ID: 25092160
[TBL] [Abstract][Full Text] [Related]
8. Microinvasive breast carcinoma: clinicopathologic analysis of a single institution experience.
Padmore RF; Fowble B; Hoffman J; Rosser C; Hanlon A; Patchefsky AS
Cancer; 2000 Mar; 88(6):1403-9. PubMed ID: 10717623
[TBL] [Abstract][Full Text] [Related]
9. Metastatic "Ductal Carcinoma In Situ-Like" Lobular Carcinoma in a Lymph Node: A Case Report and Review of the Literature.
Tijani S; Sharma K; Yuen H; Shaaban A
Int J Surg Pathol; 2020 Jun; 28(4):436-439. PubMed ID: 31789065
[TBL] [Abstract][Full Text] [Related]
10. [The difficulty of choosing a treatment strategy for ductal carcinoma in situ of the breast detected by breast cancer screening-a case report].
Suzuki S; Sakurai K; Nagashima S; Fujisaki S; Tomita R; Hara Y; Enomoto K; Amano S
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2408-10. PubMed ID: 24394128
[TBL] [Abstract][Full Text] [Related]
11. [Sentinel lymph node metastasis in patients with ductal breast carcinoma in situ].
Ruvalcaba-Limón E; de Jesús Garduño-Raya M; Bautista-Piña V; Trejo-Martínez C; Maffuz-Aziz A; Rodríguez-Cuevas S
Cir Cir; 2014; 82(2):129-41. PubMed ID: 25312311
[TBL] [Abstract][Full Text] [Related]
12. Impact of multifocality and lymph node metastasis on the prognosis and management of microinvasive breast cancer.
Kapoor NS; Shamonki J; Sim MS; Chung CT; Giuliano AE
Ann Surg Oncol; 2013 Aug; 20(8):2576-81. PubMed ID: 23468047
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of Microinvasive Ductal Carcinoma In Situ Versus Noninvasive and Invasive Breast Cancer.
Strang LR; Sun J; Sun W; Boulware D; Kiluk JV; Lee MC; Khazai L; Laronga C
J Surg Res; 2020 Oct; 254():378-383. PubMed ID: 32535256
[TBL] [Abstract][Full Text] [Related]
14. Microinvasive ductal carcinoma of the breast treated with breast-conserving surgery and definitive irradiation.
Solin LJ; Fowble BL; Yeh IT; Kowalyshyn MJ; Schultz DJ; Weiss MC; Goodman RL
Int J Radiat Oncol Biol Phys; 1992; 23(5):961-8. PubMed ID: 1322388
[TBL] [Abstract][Full Text] [Related]
15. Microinvasive breast carcinoma with extensive involvement of level III axillary lymph nodes: a case report.
Fujii K; Fukutomi T; Tsuda H; Akashi-Tanaka S; Nanasawa T; Kanai Y; Muramatsu Y
Jpn J Clin Oncol; 1998 Jan; 28(1):47-9. PubMed ID: 9491142
[TBL] [Abstract][Full Text] [Related]
16. Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer.
Curigliano G; Criscitiello C
J Clin Oncol; 2017 Aug; 35(23):2600-2603. PubMed ID: 28661760
[TBL] [Abstract][Full Text] [Related]
17. Casting-type calcifications with invasion and high-grade ductal carcinoma in situ: a more aggressive disease?
Zunzunegui RG; Chung MA; Oruwari J; Golding D; Marchant DJ; Cady B
Arch Surg; 2003 May; 138(5):537-40. PubMed ID: 12742959
[TBL] [Abstract][Full Text] [Related]
18. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion?
Klauber-DeMore N; Tan LK; Liberman L; Kaptain S; Fey J; Borgen P; Heerdt A; Montgomery L; Paglia M; Petrek JA; Cody HS; Van Zee KJ
Ann Surg Oncol; 2000 Oct; 7(9):636-42. PubMed ID: 11034239
[TBL] [Abstract][Full Text] [Related]
19. Sentinel lymph node biopsy in patients affected by breast ductal carcinoma in situ with and without microinvasion: Retrospective observational study.
Bertozzi S; Cedolini C; Londero AP; Baita B; Giacomuzzi F; Capobianco D; Tortelli M; Uzzau A; Mariuzzi L; Risaliti A
Medicine (Baltimore); 2019 Jan; 98(1):e13831. PubMed ID: 30608397
[TBL] [Abstract][Full Text] [Related]
20. Mammary ductal carcinoma in situ with microinvasion.
Silver SA; Tavassoli FA
Cancer; 1998 Jun; 82(12):2382-90. PubMed ID: 9635531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
